Medtronic acquires Sapiens

Medtronic Inc. (NYSE:MDT) acquired medical device company Sapiens Steering Brain Stimulation B.V. (Eindhoven, the Netherlands) for EUR 150 million ($200.8 million) in cash. Sapiens, which is developing deep brain stimulation technology to treat degenerative or functional brain disorders such as Parkinson's disease and dystonia, was in the top 10% of private European fundraisers in 2013 (see BioCentury, May 26). ...